TrovaGene Inc (TROV)

1.20
0.10 7.70
NASDAQ : Health Care
Prev Close 1.30
Open 1.31
Day Low/High 1.20 / 1.45
52 Wk Low/High 2.85 / 9.52
Volume 2.48M
Avg Volume 451.90K
Exchange NASDAQ
Shares Outstanding 30.97M
Market Cap 29.42M
EPS -1.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Phase 1 Safety Study Supports Planned Development Of PCM-075 In AML

Study evaluated safety, dose limiting toxicities, related maximum tolerated dose and indication of anti-tumor activity in patients with advanced or metastatic solid tumors

Short Interest Moves 16.3% Higher For TROV

The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 460,990 share increase in total short interest for TrovaGene Inc , to 3,292,918, an increase of 16.28% since 04/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Trovera™ EGFR Urine Liquid Biopsy Test Predictive Of Clinical Response To Therapy: Case Series In Patients With Non-Small Cell Lung Cancer

Authors conclude that ctDNA testing demonstrates clinical utility in assessing disease burden and response to therapy

TrovaGene (TROV) Is Today's Strong On High Volume Stock

TrovaGene (TROV) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified TrovaGene (TROV) as a strong on high relative volume candidate

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Trovagene, Inc. - TROV

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Trovagene, Inc. - TROV

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Trovagene, Inc.

Short Interest Jumps 17.6% For TROV

Short Interest Jumps 17.6% For TROV

The most recent short interest data has been released by the NASDAQ for the 02/12/2016 settlement date, which shows a 697,508 share increase in total short interest for TrovaGene Inc , to 4,657,297, an increase of 17.61% since 01/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Here’s Why TrovaGene (TROV) Stock is Soaring Today

Here’s Why TrovaGene (TROV) Stock is Soaring Today

TrovaGene (TROV) stock is spiking on Monday afternoon as the company enters an agreement with FedMed for access to cancer monitoring tests and services.

TrovaGene (TROV) Is Weak On High Volume Today

TrovaGene (TROV) Is Weak On High Volume Today

Trade-Ideas LLC identified TrovaGene (TROV) as a weak on high relative volume candidate

Trovagene (TROV) Stock Soars on America's Choice Provider Network Partnership

Trovagene (TROV) Stock Soars on America's Choice Provider Network Partnership

Trovagene (TROV) stock is climbing on heavy trading volume on Thursday after the company announced a partnership with America's Choice Provider Network.

Oversold Conditions For TrovaGene (TROV)

Oversold Conditions For TrovaGene (TROV)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TROV: Insiders vs. Shorts

TROV: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 11/30/2015 settlement date, and TrovaGene Inc is one of the most shorted stocks of the Russell 3000, based on 8.86 "days to cover" versus the median component at 6.38. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Interesting TROV Put And Call Options For July 2016

Interesting TROV Put And Call Options For July 2016

Investors in TrovaGene Inc saw new options begin trading this week, for the July 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.